Guardant Health Free Cash Flow (FCF) History (GH)
Guardant Health reported −$233.1M in free cash flow for fiscal 2025, an increase of $41.9M from the previous fiscal year, with a free cash flow margin of −23.73%.
View full Guardant Health company overviewGuardant Health free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$233.1M | $41.9M | — | −23.73% |
| 2024 | 2024-12-31 | −$274.9M | $70.5M | — | −37.20% |
| 2023 | 2023-12-31 | −$345.5M | $41.5M | — | −61.26% |
| 2022 | 2022-12-31 | −$386.9M | −$102.9M | — | −86.07% |
| 2021 | 2021-12-31 | −$284.1M | −$144.0M | — | −76.02% |
| 2020 | 2020-12-31 | −$140.1M | −$74.2M | — | −48.86% |
| 2019 | 2019-12-31 | −$65.9M | $26.5M | — | −30.72% |
| 2018 | 2018-12-31 | −$92.4M | −$13.5M | — | −101.93% |
| 2017 | 2017-12-31 | −$78.9M | — | — | −158.33% |
Guardant Health quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$69.5M | −$3.6M | — | −20.76% |
| Q1 2026 | 2026-03-31 | −$71.2M | −$4.1M | — | −23.60% |
| Q4 2025 | 2025-12-31 | −$54.2M | $29.2M | — | −19.28% |
| Q3 2025 | 2025-09-30 | −$45.8M | $9.5M | — | −17.26% |
| Q2 2025 | 2025-06-30 | −$65.9M | $33.1M | — | −28.41% |
| Q1 2025 | 2025-03-31 | −$67.1M | −$29.9M | — | −33.00% |
| Q4 2024 | 2024-12-31 | −$83.4M | −$583,000 | — | −41.32% |
| Q3 2024 | 2024-09-30 | −$55.3M | $24.9M | — | −28.86% |
| Q2 2024 | 2024-06-30 | −$99.1M | $1.4M | — | −55.90% |
| Q1 2024 | 2024-03-31 | −$37.2M | $44.7M | — | −22.09% |
| Q4 2023 | 2023-12-31 | −$82.8M | $17.9M | — | −53.40% |
| Q3 2023 | 2023-09-30 | −$80.2M | $19.7M | — | −56.05% |
| Q2 2023 | 2023-06-30 | −$100.5M | $34.4M | — | −73.30% |
| Q1 2023 | 2023-03-31 | −$82.0M | −$30.6M | — | −63.68% |
| Q4 2022 | 2022-12-31 | −$100.8M | $863,000 | — | −79.40% |
| Q3 2022 | 2022-09-30 | −$99.9M | −$24.6M | — | −85.08% |
| Q2 2022 | 2022-06-30 | −$135.0M | −$53.7M | — | −123.66% |
| Q1 2022 | 2022-03-31 | −$51.3M | −$25.4M | — | −53.40% |
| Q4 2021 | 2021-12-31 | −$101.6M | −$35.1M | — | −93.99% |
| Q3 2021 | 2021-09-30 | −$75.3M | −$57.5M | — | −79.44% |
| Q2 2021 | 2021-06-30 | −$81.3M | −$48.4M | — | −88.24% |
| Q1 2021 | 2021-03-31 | −$25.9M | −$3.0M | — | −32.90% |
| Q4 2020 | 2020-12-31 | −$66.5M | −$29.1M | — | −84.92% |
| Q3 2020 | 2020-09-30 | −$17.8M | −$13.3M | — | −23.93% |
| Q2 2020 | 2020-06-30 | −$32.9M | −$16.0M | — | −49.55% |
| Q1 2020 | 2020-03-31 | −$22.9M | −$15.9M | — | −33.89% |
| Q4 2019 | 2019-12-31 | −$37.4M | −$8.0M | — | −59.51% |
| Q3 2019 | 2019-09-30 | −$4.5M | $23.4M | — | −7.44% |
| Q2 2019 | 2019-06-30 | −$16.9M | $7.5M | — | −31.28% |
| Q1 2019 | 2019-03-31 | −$7.0M | $3.6M | — | −19.12% |
| Q4 2018 | 2018-12-31 | −$29.5M | — | — | −89.64% |
| Q3 2018 | 2018-09-30 | −$28.0M | — | — | −128.89% |
| Q2 2018 | 2018-06-30 | −$24.4M | — | — | −125.79% |
| Q1 2018 | 2018-03-31 | −$10.6M | — | — | −63.38% |
Guardant Health free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$140.1M to −$233.1M, a net decrease of $93.0M. Guardant Health's latest reported quarter, Q2 2026, generated −$69.5M in free cash flow, a decrease of $3.6M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Guardant Health filings at SEC.gov ↗